A detailed history of Victory Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Victory Financial Group, LLC holds 635 shares of LLY stock, worth $500,500. This represents 0.27% of its overall portfolio holdings.

Number of Shares
635
Previous 427 48.71%
Holding current value
$500,500
Previous $332 Million 73.07%
% of portfolio
0.27%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $150,772 - $189,080
208 Added 48.71%
635 $575 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $29,017 - $38,821
49 Added 12.96%
427 $332 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $198,521 - $234,031
378 New
378 $220 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Victory Financial Group, LLC Portfolio

Follow Victory Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Victory Financial Group, LLC with notifications on news.